Platelet Plasma Market – Global Industry Analysis and Forecast (2023-2029)

Platelet Plasma Market size is expected to reach US$ 1009 Mn. by year 2029 at a CAGR of 12.98% during the forecast period. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.Platelet Plasma MarketTo know about the Research Methodology :- Request Free Sample Report A rising incidence of haemophilia, thrombocytopenia, autoimmune diseases as well as other infectious and rare disease will serve to be a key driver for the platelet and plasma market growth. According to the American Academy of Neurology, plasma can be used for the treatment of various neurological conditions. Plasma exchange process involves replacing plasma in a person’s blood. This process can be used for the treatment of conditions such as inflammatory dis-immune neuropathies, multiple sclerosis, myasthenia gravis, and other disorders will accelerate industry growth during the forecast period Increasing blood transfusion rates in Europe will drive the Platelet, Plasma Market growth over the forecast period. Blood transfusion process is primarily done to isolate the desired blood components such as red blood cells, plasma, platelets and other vital components of the blood. Government initiatives to create awareness regarding source plasma collection, as well as the use of lifesaving plasma protein therapies in rare diseases, will positively impact the market growth. Advancements in healthcare infrastructure coupled with the increasing number of blood transfusions will directly impact the growth of Platelet, Plasma Market in the coming years. The advent of technologically advanced platelet and plasma products is another major driver that will augment the market growth. Use of platelets and plasma in the treatment of rare, debilitating, life-threatening conditions and chronic diseases such as Hepatitis B heavily influences the growth of the market. Plasma-derived from blood can be used in treating rare diseases wherein no other alternative treatment is available. For instance, use of plasma for treatment of Ebola virus during its outbreak in West Africa. Factors will augment the market growth during the forecast period. Platelet segment accounted for the largest market share and will continue to dominate the industry over the forecast period. The reason can be attributed to the increasing adoption of advanced technologies for the treatment of various diseases. Platelets are used in various surgical procedures due to its vivid therapeutic and prophylactic applications. According to the World Federation of Haemophilia (WFH), in 2022, around 2,95,866 people suffered from bleeding disorders wherein 1,84,723 accounted for hemophilia. The increasing demand of platelets for treatment of hemophilia and other blood disorders will fuel the segment growth over the forecast period. Moreover, various initiatives by the government and other organizations to encourage blood donation among people and the adoption of advanced technologies in developed and developing economies will further boost the industry growth. North America Platelet, Plasma Market accounted for the highest revenue in 2022 and is projected to grow at a significant rate during the forecast period. The growth is attributed to the increasing cases of cancer, obesity, cardiac diseases, neurological disorders, and other chronic diseases. Furthermore, American Red Cross undertakes various initiatives for increasing awareness regarding the importance of blood donation. Blood donation systems in North America are based on a mixed system of non-compensated as well as compensated donations. Moreover, the high demand for advanced technologies coupled with the availability of advanced healthcare infrastructure will augment the regional growth during the forecast period. Maximize Market Research has comprehensively analyzed Platelet, Plasma Market emphasizing on each segment keeping global and regional dynamics in perspective. The driving forces, as well as considerable restraints, have been explained in depth to attain a balanced scenario. The report classifies Platelet, Plasma Market into various segments such as Component, Distribution Channel, Applications, and Regions providing a thorough understanding of the Platelet and Plasma Ecosystem. Importantly, the report delivers forecasts of the market, giving an insight into the future opportunities that exist in the Platelet, Plasma Market. The objective of the report is to present comprehensive Platelet, Plasma Market  including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Platelet, Plasma Market  North America for Asia Pacific dynamics, structure by analyzing the market segments, and project the Platelet, Plasma Market  North America for Asia Pacific   size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Platelet, Plasma Market  North America for Asia Pacific make the report investor’s guide.

Platelet Plasma Market Scope: Inquire before buying

Platelet Plasma Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2018 to 2022 Market Size in 2022: US $ 429 Bn.
Forecast Period 2023 to 2029 CAGR: 12.98% Market Size in 2029: US $ 1009 Bn.
Segments Covered: by Component Platelet Plasma
by Application Orthopedics Cosmetic Surgery Dermatology Neurology Cardiology Ophthalmology Others
by End User Hospitals Clinics Research Institute

Platelet Plasma Market, by region

North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe) Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina, Columbia and Rest of South America)

Platelet, Plasma Market Key Players:

1. America’s Blood Centres 2. American Red Cross 3. Blood Centres of America 4. European Blood Alliance 5. Indian Red Cross Society 6. Japanese Red Cross Society 7. Red Cross Society of China 8. Spanish Red Cross 9. Saudi Red Crescent Authority 10. South Africa Red Cross Society. 11. AdiStem Ltd. 12. Arthrex, Inc. 13. Biomet, Inc. 14. Cesca Therapeutics, Inc. 15. DePuy Synthes, Inc. 16. EmCyte Corporation 17. Exactech, Inc. 18. Harvest Technologies Corp. 19. Nuo Therapeutics, Inc. 20. Regen Lab SA 21. Stryker Corporation 22. T-Biotechnology (T-LAB) 23. Arthrex, Inc 24. Terumo BCT, Inc. 25. EmCyte Corporation Frequently Asked Questions: 1. Which region has the largest share in Global Platelet, Plasma Market? Ans: North America region holds the highest share in 2022. 2. What is the growth rate of Global Platelet, Plasma Market? Ans: The Global Platelet, Plasma Market is growing at a CAGR of 12.98% during forecasting period 2023-2029. 3. What is scope of the Global Platelet, Plasma market report? Ans: Global Platelet, Plasma Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Platelet, Plasma market? Ans: The important key players in the Global Platelet, Plasma Market are – America’s Blood Centres, American Red Cross, Blood Centres of America, European Blood Alliance, Indian Red Cross Society, Japanese Red Cross Society, Red Cross Society of China, Spanish Red Cross, Saudi Red Crescent Authority, South Africa Red Cross Society., AdiStem Ltd., Arthrex, Inc., Biomet, Inc., Cesca Therapeutics, Inc., DePuy Synthes, Inc., EmCyte Corporation, Exactech, Inc., Harvest Technologies Corp., Nuo Therapeutics, Inc., Regen Lab SA, Stryker Corporation, T-Biotechnology (T-LAB), Arthrex, Inc., Terumo BCT, Inc., and EmCyte Corporation 5. What is the study period of this market? Ans: The Global Platelet, Plasma Market is studied from 2022 to 2029.
1. Platelet Plasma Market: Research Methodology 2. Platelet Plasma Market Introduction 2.1 Study Assumption and Market Definition 2.2 Scope of the Study 2.3 Executive Summary 3. Platelet Plasma Market: Dynamics 3.1 Platelet Plasma Market Trends by Region 3.1.1 North America Platelet Plasma Market Trends 3.1.2 Europe Platelet Plasma Market Trends 3.1.3 Asia Pacific Platelet Plasma Market Trends 3.1.4 Middle East and Africa Platelet Plasma Market Trends 3.1.5 South America Platelet Plasma Market Trends 3.2 Platelet Plasma Market Dynamics by Region 3.2.1 North America 3.2.1.1 North America Platelet Plasma Market Drivers 3.2.1.2 North America Platelet Plasma Market Restraints 3.2.1.3 North America Platelet Plasma Market Opportunities 3.2.1.4 North America Platelet Plasma Market Challenges 3.2.2 Europe 3.2.2.1 Europe Platelet Plasma Market Drivers 3.2.2.2 Europe Platelet Plasma Market Restraints 3.2.2.3 Europe Platelet Plasma Market Opportunities 3.2.2.4 Europe Platelet Plasma Market Challenges 3.2.3 Asia Pacific 3.2.3.1 Asia Pacific Platelet Plasma Market Drivers 3.2.3.2 Asia Pacific Platelet Plasma Market Restraints 3.2.3.3 Asia Pacific Platelet Plasma Market Opportunities 3.2.3.4 Asia Pacific Platelet Plasma Market Challenges 3.2.4 Middle East and Africa 3.2.4.1 Middle East and Africa Platelet Plasma Market Drivers 3.2.4.2 Middle East and Africa Platelet Plasma Market Restraints 3.2.4.3 Middle East and Africa Platelet Plasma Market Opportunities 3.2.4.4 Middle East and Africa Platelet Plasma Market Challenges 3.2.5 South America 3.2.5.1 South America Platelet Plasma Market Drivers 3.2.5.2 South America Platelet Plasma Market Restraints 3.2.5.3 South America Platelet Plasma Market Opportunities 3.2.5.4 South America Platelet Plasma Market Challenges 3.3 PORTER’s Five Forces Analysis 3.3.1 Bargaining Power Of Suppliers 3.3.2 Bargaining Power Of Buyers 3.3.3 Threat Of New Entrants 3.3.4 Threat Of Substitutes 3.3.5 Intensity Of Rivalry 3.4 PESTLE Analysis 3.5 Value Chain Analysis 3.6 Regulatory Landscape by Region 3.6.1 North America 3.6.2 Europe 3.6.3 Asia Pacific 3.6.4 Middle East and Africa 3.6.5 South America 3.7 Analysis of Government Schemes and Initiatives For the Platelet, Plasma Industry 3.8 The Global Pandemic and Redefining of The Platelet, Plasma Industry Landscape 3.9 Technological Road Map 4. Global Platelet Plasma Market: Global Market Size and Forecast by (Value in USD Mn) (2022-2029) 4.1 Global Platelet Plasma Market Size and Forecast, by Component (2022-2029) 4.1.1 Platelet 4.1.2 Plasma 4.2 Global Platelet Plasma Market Size and Forecast, by Application (2022-2029) 4.2.1 Orthopedics 4.2.2 Cosmetic Surgery 4.2.3 Dermatology 4.2.4 Neurology 4.2.5 Cardiology 4.2.6 Ophthalmology 4.2.7 Applications 4.3 Global Platelet Plasma Market Size and Forecast, by End User (2022-2029) 4.3.1 Hospitals 4.3.2 Clinics 4.3.3 Research Institute 4.4 Global Platelet Plasma Market Size and Forecast, by Region (2022-2029) 4.4.1 North America 4.4.2 Europe 4.4.3 Asia Pacific 4.4.4 Middle East and Africa 4.4.5 South America 5. North America Platelet Plasma Market Size and Forecast by Segmentation for Demand and Supply Side (Value and Volume) (2022-2029) 5.1 North America Platelet Plasma Market Size and Forecast, by Component (2022-2029) 5.1.1 Platelet 5.1.2 Plasma 5.2 North America Platelet Plasma Market Size and Forecast, by Application (2022-2029) 5.2.1 Orthopedics 5.2.2 Cosmetic Surgery 5.2.3 Dermatology 5.2.4 Neurology 5.2.5 Cardiology 5.2.6 Ophthalmology 5.2.7 Other 5.3 North America Platelet Plasma Market Size and Forecast, by End User (2022-2029) 5.3.1 Hospitals 5.3.2 Clinics 5.3.3 Research Institute 5.4 North America Platelet Plasma Market Size and Forecast, by Country (2022-2029) 5.4.1 United States 5.4.1.1 United States Platelet Plasma Market Size and Forecast, by Component (2022-2029) 5.4.1.1.1 Platelet 5.4.1.1.2 Plasma 5.4.1.2 United States Platelet Plasma Market Size and Forecast, by Application (2022-2029) 5.4.1.2.1 Orthopedics 5.4.1.2.2 Cosmetic Surgery 5.4.1.2.3 Dermatology 5.4.1.2.4 Neurology 5.4.1.2.5 Cardiology 5.4.1.2.6 Ophthalmology 5.4.1.2.7 Other 5.4.1.3 United States Platelet Plasma Market Size and Forecast, by End User (2022-2029) 5.4.1.3.1 Hospitals 5.4.1.3.2 Clinics 5.4.1.3.3 Research Institute 5.4.2 Canada 5.4.2.1 Canada Platelet Plasma Market Size and Forecast, by Component (2022-2029) 5.4.2.1.1 Platelet 5.4.2.1.2 Plasma 5.4.2.2 Canada Platelet Plasma Market Size and Forecast, by Application (2022-2029) 5.4.2.2.1 Orthopedics 5.4.2.2.2 Cosmetic Surgery 5.4.2.2.3 Dermatology 5.4.2.2.4 Neurology 5.4.2.2.5 Cardiology 5.4.2.2.6 Ophthalmology 5.4.2.2.7 Other 5.4.2.3 Canada Platelet Plasma Market Size and Forecast, by End User (2022-2029) 5.4.2.3.1 Hospitals 5.4.2.3.2 Clinics 5.4.2.3.3 Research Institute 5.4.3 Mexico 5.4.3.1 Mexico Platelet Plasma Market Size and Forecast, by Component (2022-2029) 5.4.3.1.1 Platelet 5.4.3.1.2 Plasma 5.4.3.2 Mexico Platelet Plasma Market Size and Forecast, by Application (2022-2029) 5.4.3.2.1 Orthopedics 5.4.3.2.2 Cosmetic Surgery 5.4.3.2.3 Dermatology 5.4.3.2.4 Neurology 5.4.3.2.5 Cardiology 5.4.3.2.6 Ophthalmology 5.4.3.2.7 Other 5.4.3.3 Mexico Platelet Plasma Market Size and Forecast, by End User (2022-2029) 5.4.3.3.1 Hospitals 5.4.3.3.2 Clinics 5.4.3.3.3 Research Institute 6. Europe Platelet Plasma Market Size and Forecast by Segmentation for (Value and Volume) (2022-2029) 6.1 Europe Platelet Plasma Market Size and Forecast, by Component (2022-2029) 6.2 Europe Platelet Plasma Market Size and Forecast, by Application (2022-2029) 6.3 Europe Platelet Plasma Market Size and Forecast, by End User (2022-2029) 6.4 Europe Platelet Plasma Market Size and Forecast, by Country (2022-2029) 6.4.1 United Kingdom 6.4.1.1 United Kingdom Platelet Plasma Market Size and Forecast, by Component (2022-2029) 6.4.1.2 United Kingdom Platelet Plasma Market Size and Forecast, by Application (2022-2029) 6.4.1.3 United Kingdom Platelet Plasma Market Size and Forecast, by End User (2022-2029) 6.4.2 France 6.4.2.1 France Platelet Plasma Market Size and Forecast, by Component (2022-2029) 6.4.2.2 France Platelet Plasma Market Size and Forecast, by Application (2022-2029) 6.4.2.3 France Platelet Plasma Market Size and Forecast, by End User (2022-2029) 6.4.3 Germany 6.4.3.1 Germany Platelet Plasma Market Size and Forecast, by Component (2022-2029) 6.4.3.2 Germany Platelet Plasma Market Size and Forecast, by Application (2022-2029) 6.4.3.3 Germany Platelet Plasma Market Size and Forecast, by End User (2022-2029) 6.4.4 Italy 6.4.4.1 Italy Platelet Plasma Market Size and Forecast, by Component (2022-2029) 6.4.4.2 Italy Platelet Plasma Market Size and Forecast, by Application (2022-2029) 6.4.4.3 Italy Platelet Plasma Market Size and Forecast, by End User (2022-2029) 6.4.5 Spain 6.4.5.1 Spain Platelet Plasma Market Size and Forecast, by Component (2022-2029) 6.4.5.2 Spain Platelet Plasma Market Size and Forecast, by Application (2022-2029) 6.4.5.3 Spain Platelet Plasma Market Size and Forecast, by End User (2022-2029) 6.4.6 Sweden 6.4.6.1 Sweden Platelet Plasma Market Size and Forecast, by Component (2022-2029) 6.4.6.2 Sweden Platelet Plasma Market Size and Forecast, by Application (2022-2029) 6.4.6.3 Sweden Platelet Plasma Market Size and Forecast, by End User (2022-2029) 6.4.7 Austria 6.4.7.1 Austria Platelet Plasma Market Size and Forecast, by Component (2022-2029) 6.4.7.2 Austria Platelet Plasma Market Size and Forecast, by Application (2022-2029) 6.4.7.3 Austria Platelet Plasma Market Size and Forecast, by End User (2022-2029) 6.4.8 Rest of Europe 6.4.8.1 Rest of Europe Platelet Plasma Market Size and Forecast, by Component (2022-2029) 6.4.8.2 Rest of Europe Platelet Plasma Market Size and Forecast, by Application (2022-2029). 6.4.8.3 Rest of Europe Platelet Plasma Market Size and Forecast, by End User (2022-2029) 7. Asia Pacific Platelet Plasma Market Size and Forecast by Segmentation for Demand and Supply Side (Value and Volume) (2022-2029) 7.1 Asia Pacific Platelet Plasma Market Size and Forecast, by Component (2022-2029) 7.2 Asia Pacific Platelet Plasma Market Size and Forecast, by Application (2022-2029) 7.3 Asia Pacific Platelet Plasma Market Size and Forecast, by End User (2022-2029) 7.4 Asia Pacific Platelet Plasma Market Size and Forecast, by Country (2022-2029) 7.4.1 China 7.4.1.1 China Platelet Plasma Market Size and Forecast, by Component (2022-2029) 7.4.1.2 China Platelet Plasma Market Size and Forecast, by Application (2022-2029) 7.4.1.3 China Platelet Plasma Market Size and Forecast, by End User (2022-2029) 7.4.2 South Korea 7.4.2.1 S Korea Platelet Plasma Market Size and Forecast, by Component (2022-2029) 7.4.2.2 S Korea Platelet Plasma Market Size and Forecast, by Application (2022-2029) 7.4.2.3 S Korea Platelet Plasma Market Size and Forecast, by End User (2022-2029) 7.4.3 Japan 7.4.3.1 Japan Platelet Plasma Market Size and Forecast, by Component (2022-2029) 7.4.3.2 Japan Platelet Plasma Market Size and Forecast, by Application (2022-2029) 7.4.3.3 Japan Platelet Plasma Market Size and Forecast, by End User (2022-2029) 7.4.4 India 7.4.4.1 India Platelet Plasma Market Size and Forecast, by Component (2022-2029) 7.4.4.2 India Platelet Plasma Market Size and Forecast, by Application (2022-2029) 7.4.4.3 India Platelet Plasma Market Size and Forecast, by End User (2022-2029) 7.4.5 Australia 7.4.5.1 Australia Platelet Plasma Market Size and Forecast, by Component (2022-2029) 7.4.5.2 Australia Platelet Plasma Market Size and Forecast, by Application (2022-2029) 7.4.5.3 Australia Platelet Plasma Market Size and Forecast, by End User (2022-2029) 7.4.6 Indonesia 7.4.6.1 Indonesia Platelet Plasma Market Size and Forecast, by Component (2022-2029) 7.4.6.2 Indonesia Platelet Plasma Market Size and Forecast, by Application (2022-2029) 7.4.6.3 Indonesia Platelet Plasma Market Size and Forecast, by End User (2022-2029) 7.4.7 Malaysia 7.4.7.1 Malaysia Platelet Plasma Market Size and Forecast, by Component (2022-2029) 7.4.7.2 Malaysia Platelet Plasma Market Size and Forecast, by Application (2022-2029) 7.4.7.3 Malaysia Platelet Plasma Market Size and Forecast, by End User (2022-2029) 7.4.8 Vietnam 7.4.8.1 Vietnam Platelet Plasma Market Size and Forecast, by Component (2022-2029) 7.4.8.2 Vietnam Platelet Plasma Market Size and Forecast, by Application (2022-2029) 7.4.8.3 Vietnam Platelet Plasma Market Size and Forecast, by End User (2022-2029) 7.4.9 Taiwan 7.4.9.1 Taiwan Platelet Plasma Market Size and Forecast, by Component (2022-2029) 7.4.9.2 Taiwan Platelet Plasma Market Size and Forecast, by Application (2022-2029) 7.4.9.3 Taiwan Platelet Plasma Market Size and Forecast, by End User (2022-2029) 7.4.10 Bangladesh 7.4.10.1 Bangladesh Platelet Plasma Market Size and Forecast, by Component (2022-2029) 7.4.10.2 Bangladesh Platelet Plasma Market Size and Forecast, by Application (2022-2029) 7.4.10.3 Bangladesh Platelet Plasma Market Size and Forecast, by End User (2022-2029) 7.4.11 Pakistan 7.4.11.1 Pakistan Platelet Plasma Market Size and Forecast, by Component (2022-2029) 7.4.11.2 Pakistan Platelet Plasma Market Size and Forecast, by Application (2022-2029) 7.4.11.3 Pakistan Platelet Plasma Market Size and Forecast, by End User (2022-2029) 7.4.12 Rest of Asia Pacific 7.4.12.1 Rest of Asia Pacific Platelet Plasma Market Size and Forecast, by Component (2022-2029) 7.4.12.2 Rest of Asia PacificPlatelet Plasma Market Size and Forecast, by Application (2022-2029) 7.4.12.3 Rest of Asia Pacific Platelet Plasma Market Size and Forecast, by End User (2022-2029) 8. Middle East and Africa Platelet Plasma Market Size and Forecast by Segmentation for Demand and Supply Side (Value and Volume) (2022-2029) 8.1 Middle East and Africa Platelet Plasma Market Size and Forecast, by Component (2022-2029) 8.2 Middle East and Africa Platelet Plasma Market Size and Forecast, by Application (2022-2029) 8.3 Middle East and Africa Platelet Plasma Market Size and Forecast, by End User (2022-2029) 8.4 Middle East and Africa Platelet Plasma Market Size and Forecast, by Country (2022-2029) 8.4.1 South Africa 8.4.1.1 South Africa Platelet Plasma Market Size and Forecast, by Component (2022-2029) 8.4.1.2 South Africa Platelet Plasma Market Size and Forecast, by Application (2022-2029) 8.4.1.3 South Africa Platelet Plasma Market Size and Forecast, by End User (2022-2029) 8.4.2 GCC 8.4.2.1 GCC Platelet Plasma Market Size and Forecast, by Component (2022-2029) 8.4.2.2 GCC Platelet Plasma Market Size and Forecast, by Application (2022-2029) 8.4.2.3 GCC Platelet Plasma Market Size and Forecast, by End User (2022-2029) 8.4.3 Egypt 8.4.3.1 Egypt Platelet Plasma Market Size and Forecast, by Component (2022-2029) 8.4.3.2 Egypt Platelet Plasma Market Size and Forecast, by Application (2022-2029) 8.4.3.3 Egypt Platelet Plasma Market Size and Forecast, by End User (2022-2029) 8.4.4 Nigeria 8.4.4.1 Nigeria Platelet Plasma Market Size and Forecast, by Component (2022-2029) 8.4.4.2 Nigeria Platelet Plasma Market Size and Forecast, by Application (2022-2029) 8.4.4.3 Nigeria Platelet Plasma Market Size and Forecast, by End User (2022-2029) 8.4.5 Rest of ME&A 8.4.5.1 Rest of ME&A Platelet Plasma Market Size and Forecast, by Component (2022-2029) 8.4.5.2 Rest of ME&A Platelet Plasma Market Size and Forecast, by Application (2022-2029) 8.4.5.3 Rest of ME&A Platelet Plasma Market Size and Forecast, by End User (2022-2029) 9. South America Platelet Plasma Market Size and Forecast by Segmentation for Demand and Supply Side (Value and Volume) (2022-2029) 9.1 South America Platelet Plasma Market Size and Forecast, by Component (2022-2029) 9.2 South America Platelet Plasma Market Size and Forecast, by Application (2022-2029) 9.3 South America Platelet Plasma Market Size and Forecast, by End User (2022-2029) 9.4 South America Platelet Plasma Market Size and Forecast, by Country (2022-2029) 9.4.1 Brazil 9.4.1.1 Brazil Platelet Plasma Market Size and Forecast, by Component (2022-2029) 9.4.1.2 Brazil Platelet Plasma Market Size and Forecast, by Application (2022-2029) 9.4.1.3 Brazil Platelet Plasma Market Size and Forecast, by End User (2022-2029) 9.4.2 Argentina 9.4.2.1 Argentina Platelet Plasma Market Size and Forecast, by Component (2022-2029) 9.4.2.2 Argentina Platelet Plasma Market Size and Forecast, by Application (2022-2029) 9.4.2.3 Argentina Platelet Plasma Market Size and Forecast, by End User (2022-2029) 9.4.3 Rest Of South America 9.4.3.1 Rest Of South America Platelet Plasma Market Size and Forecast, by Component (2022-2029) 9.4.3.2 Rest Of South America Platelet Plasma Market Size and Forecast, by Application (2022-2029) 9.4.3.3 Rest Of South America Platelet Plasma Market Size and Forecast, by End User (2022-2029) 10. Global Platelet Plasma Market: Competitive Landscape 10.1 MMR Competition Matrix 10.2 Competitive Landscape 10.3 Key Players Benchmarking 10.3.1 Company Name 10.3.2 Product Segment 10.3.3 Distribution Channelr Segment 10.3.4 Revenue (2022) 10.3.5 Manufacturing Locations 10.4 Leading Platelet, Plasma Global Companies, by market capitalization 10.5 Market Structure 10.5.1 Market Leaders 10.5.2 Market Followers 10.5.3 Emerging Players 10.6 Mergers and Acquisitions Details 11. Company Profile: Key Players 11.1 America’s Blood Centres 11.1.1 Company Overview 11.1.2 Business Portfolio 11.1.3 Financial Overview 11.1.4 SWOT Analysis 11.1.5 Strategic Analysis 11.1.6 Details on Partnership 11.1.7 Recent Developments 11.2 American Red Cross 11.3 Blood Centres of America 11.4 European Blood Alliance 11.5 Indian Red Cross Society 11.6 Japanese Red Cross Society 11.7 Red Cross Society of China 11.8 Spanish Red Cross 11.9 Saudi Red Crescent Authority 11.10 South Africa Red Cross Society. 11.11 AdiStem Ltd. 11.12 Arthrex, Inc. 11.13 Biomet, Inc. 11.14 Cesca Therapeutics, Inc. 11.15 DePuy Synthes, Inc. 11.16 EmCyte Corporation 11.17 Exactech, Inc. 11.18 Harvest Technologies Corp. 11.19 Nuo Therapeutics, Inc. 11.20 Regen Lab SA 11.21 Stryker Corporation 11.22 T-Biotechnology (T-LAB) 11.23 Arthrex, Inc 11.24 Terumo BCT, Inc. 11.25 EmCyte Corporation. 12. Key Findings 13. Industry Recommendations 14. Terms and Glossary

About This Report

Report ID 11293
Category Healthcare
Published Date DEC 2023
Updated Date
  • INQUIRE BEFORE BUYING